These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3528346

  • 1. Adoptive transfer of tolerance induced by ICRC bacilli against Mycobacterium leprae in mice.
    Jeevan A, Bapat CV, Deo MG.
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):437-45. PubMed ID: 3528346
    [Abstract] [Full Text] [Related]

  • 2. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A, Bapat CV.
    Indian J Lepr; 1984 Sep; 56(4):754-63. PubMed ID: 6398339
    [Abstract] [Full Text] [Related]

  • 3. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
    Bapat CV.
    Acta Leprol; 1984 Sep; 2(2-4):175-94. PubMed ID: 6442820
    [Abstract] [Full Text] [Related]

  • 4. Antigeneic cross-reactivity between ICRC-bacilli and M. leprae--"in vitro" evaluation.
    Kale VP, Bapat CV.
    Indian J Lepr; 1984 Sep; 56(2):219-31. PubMed ID: 6387004
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
    Bapat CV, Modak MS, DeSouza NG, Chulawalla RG.
    Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
    [Abstract] [Full Text] [Related]

  • 6. Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae.
    Shepard CC, Minagawa F, Van Landingham R, Walker LL.
    Int J Lepr Other Mycobact Dis; 1980 Dec; 48(4):371-81. PubMed ID: 7009447
    [Abstract] [Full Text] [Related]

  • 7. Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
    Aarestrup FM, Sampaio EP, de Moraes MO, Albuquerque EC, Castro AP, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):156-66. PubMed ID: 11036496
    [Abstract] [Full Text] [Related]

  • 8. Reconstitution of Mycobacterium leprae immunity in severe combined immunodeficient mice using a T-cell line.
    Azouaou N, Gelber RH, Abel K, Sasaki DT, Murray LP, Locksley RM, Mohagheghpour N.
    Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):398-405. PubMed ID: 8228438
    [Abstract] [Full Text] [Related]

  • 9. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH, Rees RH, Liew FY.
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [Abstract] [Full Text] [Related]

  • 10. Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.
    Smelt AH, Rees RJ, Liew FY.
    Clin Exp Immunol; 1981 Jun; 44(3):501-6. PubMed ID: 7035030
    [Abstract] [Full Text] [Related]

  • 11. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
    Bjune G.
    Int J Lepr Other Mycobact Dis; 1978 Jun; 46(3-4):386-93. PubMed ID: 83309
    [Abstract] [Full Text] [Related]

  • 12. Growth of the ICRC bacilli in the foot-pad of mice.
    Bapat CV, Modak MS.
    Lepr India; 1978 Apr; 50(2):144-55. PubMed ID: 353383
    [Abstract] [Full Text] [Related]

  • 13. Sensitization or tolerance to Mycobacterium leprae antigen by route of injection.
    Shepard CC, Walker LL, Van Landingham RM, Ye SZ.
    Infect Immun; 1982 Nov; 38(2):673-80. PubMed ID: 6754621
    [Abstract] [Full Text] [Related]

  • 14. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR, Chiplunkar SV, Butlin R, Samson PD, Deo MG, Gangal SG.
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [Abstract] [Full Text] [Related]

  • 15. Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens.
    Collins FM, Morrison NE, Watson SR.
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):481-9. PubMed ID: 6423556
    [Abstract] [Full Text] [Related]

  • 16. Adoptively transferred reactivity to M. leprae in nude mice infected with M. leprae.
    Shannon EJ, Chehl S, Job CK, Hastings RC.
    Clin Exp Immunol; 1987 Oct; 70(1):143-51. PubMed ID: 3319298
    [Abstract] [Full Text] [Related]

  • 17. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS.
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [Abstract] [Full Text] [Related]

  • 18. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J.
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [Abstract] [Full Text] [Related]

  • 19. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM.
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [Abstract] [Full Text] [Related]

  • 20. A vaccine from ICRC bacilli against M. leprae infection in mouse foot-pad.
    Bhide MB, Pradhan KS, Bapat CV.
    Lepr India; 1978 Jul; 50(3):334-44. PubMed ID: 359922
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.